- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NHE: 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID(Non-covalent)
NHE.2: 7 residues within 4Å:- Chain A: F.387, F.477, Y.478, D.479, V.482, N.496, I.499
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:F.387, A:F.477
- Hydrogen bonds: A:F.477, A:F.477, A:D.479
- Water bridges: A:D.479
NHE.15: 7 residues within 4Å:- Chain B: F.387, F.477, Y.478, D.479, V.482, N.496, I.499
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:F.387, B:F.477
- Hydrogen bonds: B:F.477, B:F.477, B:D.479
NHE.28: 7 residues within 4Å:- Chain C: F.387, F.477, Y.478, D.479, V.482, N.496, I.499
6 PLIP interactions:6 interactions with chain C- Hydrophobic interactions: C:F.387, C:F.477
- Hydrogen bonds: C:F.477, C:F.477, C:D.479
- Water bridges: C:D.479
- 30 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 4 residues within 4Å:- Chain C: R.235, E.236, V.239, N.240
Ligand excluded by PLIPSO4.4: 3 residues within 4Å:- Chain A: C.358, K.359, V.360
Ligand excluded by PLIPSO4.5: 6 residues within 4Å:- Chain A: F.137, L.138, G.139, Q.354
- Ligands: 6YA.26, 6YA.39
Ligand excluded by PLIPSO4.6: 4 residues within 4Å:- Chain A: E.328, G.418, K.419
- Chain C: P.376
Ligand excluded by PLIPSO4.7: 4 residues within 4Å:- Chain A: S.443, K.445, G.464, S.466
Ligand excluded by PLIPSO4.8: 3 residues within 4Å:- Chain A: N.276, N.277, R.364
Ligand excluded by PLIPSO4.9: 3 residues within 4Å:- Chain A: N.444, G.446, K.461
Ligand excluded by PLIPSO4.10: 3 residues within 4Å:- Chain A: N.325, T.326, K.327
Ligand excluded by PLIPSO4.11: 2 residues within 4Å:- Chain A: K.85
- Chain B: Q.224
Ligand excluded by PLIPSO4.12: 8 residues within 4Å:- Chain A: R.49, W.52, S.146, A.147, M.370
- Chain B: L.456, Y.457, Y.458
Ligand excluded by PLIPSO4.16: 4 residues within 4Å:- Chain A: R.235, E.236, V.239, N.240
Ligand excluded by PLIPSO4.17: 3 residues within 4Å:- Chain B: C.358, K.359, V.360
Ligand excluded by PLIPSO4.18: 6 residues within 4Å:- Chain B: F.137, L.138, G.139, Q.354
- Ligands: 6YA.13, 6YA.39
Ligand excluded by PLIPSO4.19: 4 residues within 4Å:- Chain A: P.376
- Chain B: E.328, G.418, K.419
Ligand excluded by PLIPSO4.20: 4 residues within 4Å:- Chain B: S.443, K.445, G.464, S.466
Ligand excluded by PLIPSO4.21: 3 residues within 4Å:- Chain B: N.276, N.277, R.364
Ligand excluded by PLIPSO4.22: 3 residues within 4Å:- Chain B: N.444, G.446, K.461
Ligand excluded by PLIPSO4.23: 3 residues within 4Å:- Chain B: N.325, T.326, K.327
Ligand excluded by PLIPSO4.24: 2 residues within 4Å:- Chain B: K.85
- Chain C: Q.224
Ligand excluded by PLIPSO4.25: 8 residues within 4Å:- Chain B: R.49, W.52, S.146, A.147, M.370
- Chain C: L.456, Y.457, Y.458
Ligand excluded by PLIPSO4.29: 4 residues within 4Å:- Chain B: R.235, E.236, V.239, N.240
Ligand excluded by PLIPSO4.30: 3 residues within 4Å:- Chain C: C.358, K.359, V.360
Ligand excluded by PLIPSO4.31: 6 residues within 4Å:- Chain C: F.137, L.138, G.139, Q.354
- Ligands: 6YA.13, 6YA.26
Ligand excluded by PLIPSO4.32: 4 residues within 4Å:- Chain B: P.376
- Chain C: E.328, G.418, K.419
Ligand excluded by PLIPSO4.33: 4 residues within 4Å:- Chain C: S.443, K.445, G.464, S.466
Ligand excluded by PLIPSO4.34: 3 residues within 4Å:- Chain C: N.276, N.277, R.364
Ligand excluded by PLIPSO4.35: 3 residues within 4Å:- Chain C: N.444, G.446, K.461
Ligand excluded by PLIPSO4.36: 3 residues within 4Å:- Chain C: N.325, T.326, K.327
Ligand excluded by PLIPSO4.37: 2 residues within 4Å:- Chain A: Q.224
- Chain C: K.85
Ligand excluded by PLIPSO4.38: 8 residues within 4Å:- Chain A: L.456, Y.457, Y.458
- Chain C: R.49, W.52, S.146, A.147, M.370
Ligand excluded by PLIP- 3 x 6YA: 3-[[5-chloranyl-1-(3-methylsulfonylpropyl)indol-2-yl]methyl]-1-[2,2,2-tris(fluoranyl)ethyl]imidazo[4,5-c]pyridin-2-one(Non-covalent)
6YA.13: 16 residues within 4Å:- Chain A: F.140, F.488, D.489
- Chain B: F.137, F.140, M.396, T.397, D.486, E.487, F.488
- Chain C: F.137, F.488
- Ligands: SO4.18, 6YA.26, SO4.31, 6YA.39
12 PLIP interactions:6 interactions with chain B, 4 interactions with chain A, 2 interactions with chain C- Hydrophobic interactions: B:F.488, B:F.488, B:F.488, B:F.488, A:F.140, A:F.488, A:D.489
- pi-Stacking: B:F.140, A:F.488, C:F.488, C:F.488
- Halogen bonds: B:T.397
6YA.26: 16 residues within 4Å:- Chain A: F.137, F.488
- Chain B: F.140, F.488, D.489
- Chain C: F.137, F.140, M.396, T.397, D.486, E.487, F.488
- Ligands: SO4.5, 6YA.13, SO4.31, 6YA.39
12 PLIP interactions:4 interactions with chain B, 2 interactions with chain A, 6 interactions with chain C- Hydrophobic interactions: B:F.140, B:F.488, B:D.489, C:F.488, C:F.488, C:F.488, C:F.488
- pi-Stacking: B:F.488, A:F.488, A:F.488, C:F.140
- Halogen bonds: C:T.397
6YA.39: 16 residues within 4Å:- Chain A: F.137, F.140, M.396, T.397, D.486, E.487, F.488
- Chain B: F.137, F.488
- Chain C: F.140, F.488, D.489
- Ligands: SO4.5, 6YA.13, SO4.18, 6YA.26
12 PLIP interactions:2 interactions with chain B, 6 interactions with chain A, 4 interactions with chain C- pi-Stacking: B:F.488, B:F.488, A:F.140, C:F.488
- Hydrophobic interactions: A:F.488, A:F.488, A:F.488, A:F.488, C:F.140, C:F.488, C:D.489
- Halogen bonds: A:T.397
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Roymans, D. et al., Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor. Nat Commun (2017)
- Release Date
- 2017-08-02
- Peptides
- Fusion glycoprotein F0, Envelope glycoprotein chimera: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
FB
FC
F
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NHE: 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID(Non-covalent)
- 30 x SO4: SULFATE ION(Non-functional Binders)
- 3 x 6YA: 3-[[5-chloranyl-1-(3-methylsulfonylpropyl)indol-2-yl]methyl]-1-[2,2,2-tris(fluoranyl)ethyl]imidazo[4,5-c]pyridin-2-one(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Roymans, D. et al., Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor. Nat Commun (2017)
- Release Date
- 2017-08-02
- Peptides
- Fusion glycoprotein F0, Envelope glycoprotein chimera: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
FB
FC
F